home
about us
delivery platforms
product pipeline
subsidiaries
news and events
contact us
about us
about us
careers
benefits
current openings
fact sheet
history
leadership
recent news
MicroDose Therapeutx Announces Successful Conclusion of Safety Study in Asthmatic Patients for MDT-637 and Presentation of Overall Phase 1 Results at the 8th Annual International Respiratory Syncytial Virus (RSV) Symposium
MicroDose Therapeutx Fact Sheet
